NIH To Limit Money To Well-Funded Investigators?

By Bouvier Grant Group

We stay current on NIH happenings and would be delighted to keep you informed.

Dr. Sally Rockey, Deputy Director for Extramural Research at NIH, posted in her blog “Rock Talk” about the possibility of NIH limiting funds to already funded investigators. Decisions were to be made at September Council, so we should be getting some information about this program soon. From the original blog post:

“It’s been three months since I discussed how, during May Advisory Council meetings, NIH would pilot a new Special Council Review process for particularly well-funded applicants (NOTE that they have now dropped the amount to $1M in directs to trigger a council review). Since that time, we ran the pilot and carefully considered all the great feedback we received from Advisory Council members and staff. We are now ready to implement the final policy on Special Council Review.

“The new special review process will be in effect for the 2013 fiscal year, beginning with September 2012 Council meetings. The new policy will provide additional consideration of new and renewal applications from well-supported investigators who currently receive more than $1 million or more in direct costs. I want to remind you that this policy does not cap the total amount of funds an investigator may receive from NIH, but rather is a special review to complement existing NIH policies that require monitoring all investigators’ activities for overlapping support, and determining whether additional funds should be awarded to well-supported investigators.”

For the full blog post and all comments, click here: NIH Extramural Nexus.

Author:
Dr. Meg Bouvier

Margaret Bouvier received her PhD in 1995 in Biomedical Sciences from the Mount Sinai School of Medicine. After an NINDS post-doctoral fellowship, she worked as a staff writer for long-standing NIH Director Dr. Francis Collins in the Office of Press, Policy, and Communications for the Human Genome Project and NHGRI. Since 2007, Meg has specialized in editing and advising on NIH submissions, and began offering virtual courses in 2015. She's recently worked with more than 40% of the nation's highest-performing hospitals*, four of the top 10 cancer hospitals, three of the top five medical schools for research, and 14 NCI-designated cancer centers. Her experience at NIH as both a bench scientist and staff writer greatly informs her approach to NIH grantwriting. She has helped clients land over half a billion in federal funding. Bouvier Grant Group is a woman-owned small business.

*Our clients include 9 of the top 22 hospitals as recognized by the 2023/24 US News & World Report honor roll

Categories:
We read all NIH notices for our clients. When you join our mailing list, we’ll pass along important changes directly to your inbox, as well as opportunities to improve your grantsmanship skills.
Primary Position
Lead Source

Wait!

Subscribe to our monthly newsletter for the latest NIH news, grantwriting tips, and more.

NIH-October-2023-Newsletter